SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India informs about trading window closure

26 Dec 2024 Evaluate

Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015 and Granules Code of Conduct for Prevention of Insider Trading, Granules India has informed that the Trading Window for dealing in the securities of the Company shall remain closed for all Insiders including the Designated Persons and their immediate relatives from January 01, 2025 till 48 hours after the declaration of the unaudited financial results for the nine-months and quarter ending on December 31, 2024.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×